United States Next Generation Sequencing Market Growth, Demand and Challenges of the Key Industry Players 2032

1
United States Next Generation Sequencing Market
Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "United States Next Generation Sequencing
  Market Industry Trends, Share, Size, Growth,
  Opportunity and Forecast 2024-2032," the United
  States next generation sequencing market size is
  projected to exhibit a growth rate (CAGR) of XX
  during 2024-2032.
• The United States next generation sequencing
  (NGS) market is experiencing significant growth,
  propelled by the increasing application of NGS
  technologies in clinical diagnostics, drug
  discovery, and personalized medicine.
  Additionally, the ongoing advancements in NGS
  platforms, which offer higher accuracy, speed,
  and reduced sequencing costs, are stimulating the
  market growth.
• This technological evolution is enabling
  widespread adoption in various fields, including
  oncology, genetic disorders, and infectious
  diseases, where precise genomic insights are
  crucial. Moreover, the rising emphasis on
  precision medicine and the growing prevalence of
  chronic diseases has heightened the demand for
  NGS to better understand disease genetics and
  create tailored therapies, which are further
  augmenting the market growth.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/united-states-next-gene
  ration-sequencing-market/requestsample

4
Report Description

• United States Next Generation Sequencing Market
  Trends
• Besides this, the expanding research and
  development activities in genomics, backed by
  substantial funding from both government and
  private entities are boosting the United States
  next generation sequencing market. Moreover, the
  increasing collaborations between academic
  institutions, healthcare providers, and
  biotechnology companies to encourage innovation
  and expand the range of NGS applications are
  acting as other significant factors.
• Additionally, the incorporation of machine
  learning and artificial intelligence with NGS
  data analysis to enhance the efficiency of
  genomic research and clinical diagnostics is
  creating a positive outlook for the market.
  Furthermore, the increasing adoption of NGS in
  prenatal testing, cancer screening, and rare
  disease diagnosis are also contributing to the
  market growth. Besides this, the ongoing
  technological advancements and the integration of
  NGS in routine clinical practice are expected to
  drive the United States next generation
  sequencing market in the coming years.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/united-states-next-gene
  ration-sequencing-market

5
Report Segmentation

• Sequencing Type Insights
• Whole Genome Sequencing
• Targeted Resequencing
• Whole Exome Sequencing
• RNA Sequencing
• CHIP Sequencing
• De Novo Sequencing
• Methyl Sequencing
• Others
• Product Type Insights
• Instruments
• Reagents and Consumables
• Software and Services

6
Report Segmentation

• Technology Insights
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time Sequencing
• Nanopore Sequencing
• Others
• Application Insights
• Biomarker and Cancer
• Drug Discovery and Personalized Medicine
• Genetic Screening
• Diagnostics
• Agriculture and Animal Research

7
Report Segmentation

• Others
• End User Insights
• Academic Institutes and Research Centers
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others
• Regional Insights
• Northeast
• Midwest
• South
• West

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4   United
  States Next Generation Sequencing Market -
  Introduction    4.1    Overview    4.2  
   Market Dynamics    4.3    Industry Trends   
  4.4    Competitive Intelligence5   United States
  Next Generation Sequencing Market Landscape   
  5.1    Historical and Current Market Trends
  (2018-2023)    5.2    Market Forecast
  (?2024-2032)6   United States Next Generation
  Sequencing Market - Breakup by Sequencing Type 
    6.1    Whole Genome Sequencing        6.1.1
  Overview        6.1.2 Historical and Current
  Market Trends (2018-2023)        6.1.3 Market
  Forecast (?2024-2032)    6.2    Targeted
  Resequencing        6.2.1 Overview        6.2.2
  Historical and Current Market Trends
  (2018-2023)        6.2.3 Market Forecast
  (?2024-2032)       

11
Table of Contents

•     6.3    Whole Exome Sequencing        6.3.1
  Overview        6.3.2 Historical and Current
  Market Trends (2018-2023)        6.3.3 Market
  Forecast (?2024-2032)    6.4    RNA Sequencing 
        6.4.1 Overview        6.4.2 Historical and
  Current Market Trends (2018-2023)        6.4.3
  Market Forecast (?2024-2032)    6.5    CHIP
  Sequencing        6.5.1 Overview        6.5.2
  Historical and Current Market Trends
  (2018-2023)        6.5.3 Market Forecast
  (?2024-2032)    6.6    De Novo Sequencing     
    6.6.1 Overview        6.6.2 Historical and
  Current Market Trends (2018-2023)        6.6.3
  Market Forecast (?2024-2032)    6.7    Methyl
  Sequencing        6.7.1 Overview        6.7.2
  Historical and Current Market Trends
  (2018-2023)        6.7.3 Market Forecast
  (?2024-2032)    6.8    Others        6.8.1
  Historical and Current Market Trends
  (2018-2023)        6.8.2 Market Forecast
  (?2024-2032)7   United States Next Generation
  Sequencing Market - Breakup by Product Type   
  7.1    Instruments        7.1.1 Overview       
  7.1.2 Historical and Current Market Trends
  (2018-2023)        7.1.3 Market Forecast
  (?2024-2032)
• For more information, visit https//www.imarcgrou
  p.com/united-states-next-generation-sequencing-mar
  ket/toc

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com